Discover

News & Info

Trade

LongbridgeAI

Quote List Quote List

ALTAMIRA THERAPEUTICS LTD(CYTOF.US)

Event Tracking

Mar24

ALTAMIRA THERAPEUTICS LTD to Release FY2025 Annual Earnings on March 31, 2026 Pre-Market EST

00:10

Dec19

Altamira Medica Receives NMPA Market Approval for Bentrio Nasal Spray

14:00

Nov20

Altamira Medica Obtains EU MDR Certification for Bentrio Nasal Spray

14:01

Aug30

Altamira Therapeutics Ltd released FY2025 Q1 earnings on August 29 (EST), actual revenue USD 0, actual EPS USD -0.1529

03:00

Aug29

Altamira Therapeutics Ltd released FY2025 Q2 earnings on August 29 Pre-Market EST, actual revenue USD 0, actual EPS USD -0.1529

13:30

Altamira Therapeutics Ltd released FY2025 Semi-Annual Earnings on August 29 Pre-Market (EST), Actual Revenue: USD 0 (Forecast: USD 0), Actual EPS: USD -0.3059 (Forecast: USD --)

13:30

Schedules & Filings

Schedules

Filings

Mar31

Earning Release(EST)

FY2025 Annual Earning Release

Aug29

Earning Release(EST)

FY2025 Q2 Earning Release (USD) Net Income -767.51 K, EPS -0.1529

Apr30

Earning Release(EST)

FY2024 Q4 Earning Release (USD) Net Income -2.059 M, EPS -0.5713

Stock List

Top Gainers

Top Decliners

China Concepts

Symbol

Price

%Chg

Change

ALTAMIRA THERAPEUTICS LTD(CYTOF.US)

ALTAMIRA THERAPEUTICS LTD Stock Performance Chart

Trending